Impaired	B:C0518456
mobility	I:C0518456
,	O
depressed	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
are	O
independently	O
associated	O
with	O
disability	O
in	O
older	O
cancer	O
outpatients	O
:	O

Impaired	O
mobility	I:C0518456
,	O
depressed	B:C0344315
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
are	O
independently	O
associated	O
with	O
disability	O
in	O
older	O
cancer	O
outpatients	O
:	O

Impaired	O
mobility	I:C0518456
,	O
depressed	O
mood	I:C0344315
,	O
cognitive	B:C0338656
impairment	I:C0338656
and	O
polypharmacy	O
are	O
independently	O
associated	O
with	O
disability	O
in	O
older	O
cancer	O
outpatients	O
:	O

Impaired	O
mobility	I:C0518456
,	O
depressed	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	B:C2922974
are	O
independently	O
associated	O
with	O
disability	O
in	O
older	O
cancer	O
outpatients	O
:	O

Impaired	O
mobility	I:C0518456
,	O
depressed	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
are	O
independently	O
associated	O
with	O
disability	B:C0231170
in	O
older	O
cancer	O
outpatients	O
:	O

Impaired	O
mobility	I:C0518456
,	O
depressed	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
are	O
independently	O
associated	O
with	O
disability	O
in	O
older	O
cancer	B:C0006826
outpatients	O
:	O

The	O
prospective	O
Physical	B:C0424594
Frailty	I:C0424594
in	O
Elderly	O
Cancer	O
patients	O
(	O
PF	O
-	O
EC	O
)	O
cohort	O
study	O
.	O

The	O
prospective	O
Physical	O
Frailty	I:C0424594
in	O
Elderly	B:C0001792
Cancer	O
patients	O
(	O
PF	O
-	O
EC	O
)	O
cohort	O
study	O
.	O

The	O
prospective	O
Physical	O
Frailty	I:C0424594
in	O
Elderly	O
Cancer	O
patients	O
(	O
PF	B:C0424594
-	O
EC	O
)	O
cohort	O
study	O
.	O

To	O
assess	O
the	O
prevalence	O
of	O
disability	B:C0231170
and	O
the	O
oncologic	O
factors	O
associated	O
with	O
disability	O
in	O
older	O
outpatients	O
with	O
cancer	O
.	O

To	O
assess	O
the	O
prevalence	O
of	O
disability	O
and	O
the	O
oncologic	O
factors	O
associated	O
with	O
disability	B:C0231170
in	O
older	O
outpatients	O
with	O
cancer	O
.	O

To	O
assess	O
the	O
prevalence	O
of	O
disability	O
and	O
the	O
oncologic	O
factors	O
associated	O
with	O
disability	O
in	O
older	O
outpatients	O
with	O
cancer	B:C0006826
.	O

The	O
Physical	B:C0424594
Frailty	I:C0424594
in	O
Elderly	O
Cancer	O
patients	O
(	O
PF	O
-	O
EC	O
)	O
study	O
(	O
France	O
)	O
is	O
a	O
prospective	O
bicentric	I:C1709709
observational	I:C1709709
cohort	I:C1709709
study	I:C1709709
.	O

The	O
Physical	O
Frailty	I:C0424594
in	O
Elderly	B:C0001792
Cancer	O
patients	O
(	O
PF	O
-	O
EC	O
)	O
study	O
(	O
France	O
)	O
is	O
a	O
prospective	O
bicentric	I:C1709709
observational	I:C1709709
cohort	I:C1709709
study	I:C1709709
.	O

The	O
Physical	O
Frailty	I:C0424594
in	O
Elderly	O
Cancer	O
patients	O
(	O
PF	B:C0424594
-	O
EC	O
)	O
study	O
(	O
France	O
)	O
is	O
a	O
prospective	O
bicentric	I:C1709709
observational	I:C1709709
cohort	I:C1709709
study	I:C1709709
.	O

The	O
Physical	O
Frailty	I:C0424594
in	O
Elderly	O
Cancer	O
patients	O
(	O
PF	O
-	O
EC	O
)	O
study	O
(	O
France	B:C0016674
)	O
is	O
a	O
prospective	O
bicentric	I:C1709709
observational	I:C1709709
cohort	I:C1709709
study	I:C1709709
.	O

The	O
Physical	O
Frailty	I:C0424594
in	O
Elderly	O
Cancer	O
patients	O
(	O
PF	O
-	O
EC	O
)	O
study	O
(	O
France	O
)	O
is	O
a	O
prospective	B:C1709709
bicentric	I:C1709709
observational	I:C1709709
cohort	I:C1709709
study	I:C1709709
.	O

Two	O
hundred	O
and	O
ninety	O
outpatients	O
with	O
cancer	B:C0006826
were	O
included	O
.	O

A	O
cross-sectional	B:C0010362
analysis	I:C0010362
of	O
oncologic	O
factors	O
and	O
geriatric	O
variables	O
associated	O
with	O
disability	O
that	O
were	O
collected	O
using	O
a	O
comprehensive	O
geriatric	O
assessment	I:C0017463
(	O
comprehensive	O
geriatric	I:C0017463
assessment	I:C0017463
)	O
was	O
conducted	O
.	O

A	O
cross-sectional	O
analysis	I:C0010362
of	O
oncologic	O
factors	O
and	O
geriatric	O
variables	O
associated	O
with	O
disability	B:C0231170
that	O
were	O
collected	O
using	O
a	O
comprehensive	O
geriatric	O
assessment	I:C0017463
(	O
comprehensive	O
geriatric	I:C0017463
assessment	I:C0017463
)	O
was	O
conducted	O
.	O

A	O
cross-sectional	O
analysis	I:C0010362
of	O
oncologic	O
factors	O
and	O
geriatric	O
variables	O
associated	O
with	O
disability	O
that	O
were	O
collected	O
using	O
a	O
comprehensive	O
geriatric	B:C0017463
assessment	I:C0017463
(	O
comprehensive	O
geriatric	I:C0017463
assessment	I:C0017463
)	O
was	O
conducted	O
.	O

A	O
cross-sectional	O
analysis	I:C0010362
of	O
oncologic	O
factors	O
and	O
geriatric	O
variables	O
associated	O
with	O
disability	O
that	O
were	O
collected	O
using	O
a	O
comprehensive	O
geriatric	O
assessment	I:C0017463
(	O
comprehensive	B:C0017463
geriatric	I:C0017463
assessment	I:C0017463
)	O
was	O
conducted	O
.	O

Disability	B:C0231170
was	O
defined	O
as	O
impairment	O
in	O
activities	O
of	O
daily	O
living	O
(	O
ADL	O
)	O
and	O
/	O
or	O
instrumental	O
activities	I:C1290928
of	I:C1290928
daily	I:C1290928
living	I:C1290928
(	O
IADL	I:C1290928
)	O
,	O
simplified	O
to	O
four	O
items	O
.	O

Disability	O
was	O
defined	O
as	O
impairment	O
in	O
activities	O
of	O
daily	O
living	O
(	O
ADL	O
)	O
and	O
/	O
or	O
instrumental	B:C1290928
activities	I:C1290928
of	I:C1290928
daily	I:C1290928
living	I:C1290928
(	O
IADL	I:C1290928
)	O
,	O
simplified	O
to	O
four	O
items	O
.	O

Disability	O
was	O
defined	O
as	O
impairment	O
in	O
activities	O
of	O
daily	O
living	O
(	O
ADL	O
)	O
and	O
/	O
or	O
instrumental	O
activities	I:C1290928
of	I:C1290928
daily	I:C1290928
living	I:C1290928
(	B:C1290928
IADL	I:C1290928
)	O
,	O
simplified	O
to	O
four	O
items	O
.	O

Univariate	O
and	O
multivariate	O
logistic	B:C0023965
models	I:C0023965
of	O
disabled	O
patients	O
were	O
performed	O
.	O

The	O
three	O
final	O
multivariate	O
models	B:C0023965
were	O
compared	O
using	O
the	O
area	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
(	O
AUC	O
/	O
ROC	O
)	O
of	O
the	O
logistic	O
model	I:C0023965
.	O

The	O
three	O
final	O
multivariate	O
models	O
were	O
compared	O
using	O
the	O
area	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
(	O
AUC	O
/	O
ROC	O
)	O
of	O
the	O
logistic	B:C0023965
model	I:C0023965
.	O

The	O
mean	O
age	O
was	O
80.6	O
years	O
,	O
and	O
51	O
%	O
of	O
the	O
patients	O
were	O
women	B:C0043210
with	O
various	O
types	O
of	O
cancer	O
.	O

The	O
mean	O
age	O
was	O
80.6	O
years	O
,	O
and	O
51	O
%	O
of	O
the	O
patients	O
were	O
women	O
with	O
various	O
types	O
of	O
cancer	B:C0006826
.	O

The	O
prevalence	O
of	O
disability	B:C0231170
was	O
67.6	O
%	O
.	O

No	O
oncologic	O
factors	O
(	O
cancer	O
site	O
,	O
cancer	B:C1704231
extension	I:C1704231
)	O
were	O
associated	O
with	O
disability	O
.	O

No	O
oncologic	O
factors	O
(	O
cancer	O
site	O
,	O
cancer	O
extension	I:C1704231
)	O
were	O
associated	O
with	O
disability	B:C0231170
.	O

Impaired	B:C0518456
mobility	I:C0518456
,	O
poor	O
functional	I:C0598463
status	I:C0598463
,	O
depressive	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
were	O
independently	O
associated	O
with	O
disability	O
(	O
P<	O
0.05	O
)	O
.	O

Impaired	O
mobility	I:C0518456
,	O
poor	B:C0598463
functional	I:C0598463
status	I:C0598463
,	O
depressive	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
were	O
independently	O
associated	O
with	O
disability	O
(	O
P<	O
0.05	O
)	O
.	O

Impaired	O
mobility	I:C0518456
,	O
poor	O
functional	I:C0598463
status	I:C0598463
,	O
depressive	B:C0344315
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
were	O
independently	O
associated	O
with	O
disability	O
(	O
P<	O
0.05	O
)	O
.	O

Impaired	O
mobility	I:C0518456
,	O
poor	O
functional	I:C0598463
status	I:C0598463
,	O
depressive	O
mood	I:C0344315
,	O
cognitive	B:C0338656
impairment	I:C0338656
and	O
polypharmacy	O
were	O
independently	O
associated	O
with	O
disability	O
(	O
P<	O
0.05	O
)	O
.	O

Impaired	O
mobility	I:C0518456
,	O
poor	O
functional	I:C0598463
status	I:C0598463
,	O
depressive	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	B:C2922974
were	O
independently	O
associated	O
with	O
disability	O
(	O
P<	O
0.05	O
)	O
.	O

Impaired	O
mobility	I:C0518456
,	O
poor	O
functional	I:C0598463
status	I:C0598463
,	O
depressive	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
were	O
independently	O
associated	O
with	O
disability	B:C0231170
(	O
P<	O
0.05	O
)	O
.	O

Disability	B:C0231170
was	O
highly	O
prevalent	O
in	O
older	O
cancer	O
outpatients	O
before	O
cancer	O
treatment	I:C0920425
but	O
was	O
not	O
associated	O
with	O
oncologic	O
factors	O
.	O

Disability	O
was	O
highly	O
prevalent	O
in	O
older	O
cancer	B:C0006826
outpatients	O
before	O
cancer	O
treatment	I:C0920425
but	O
was	O
not	O
associated	O
with	O
oncologic	O
factors	O
.	O

Disability	O
was	O
highly	O
prevalent	O
in	O
older	O
cancer	O
outpatients	O
before	O
cancer	B:C0920425
treatment	I:C0920425
but	O
was	O
not	O
associated	O
with	O
oncologic	O
factors	O
.	O

Impaired	B:C0518456
mobility	I:C0518456
,	O
depressed	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
were	O
the	O
geriatric	O
variables	O
significantly	O
and	O
independently	O
associated	O
with	O
disability	O
.	O

Impaired	O
mobility	I:C0518456
,	O
depressed	B:C0344315
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
were	O
the	O
geriatric	O
variables	O
significantly	O
and	O
independently	O
associated	O
with	O
disability	O
.	O

Impaired	O
mobility	I:C0518456
,	O
depressed	O
mood	I:C0344315
,	O
cognitive	B:C0338656
impairment	I:C0338656
and	O
polypharmacy	O
were	O
the	O
geriatric	O
variables	O
significantly	O
and	O
independently	O
associated	O
with	O
disability	O
.	O

Impaired	O
mobility	I:C0518456
,	O
depressed	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	B:C2922974
were	O
the	O
geriatric	O
variables	O
significantly	O
and	O
independently	O
associated	O
with	O
disability	O
.	O

Impaired	O
mobility	I:C0518456
,	O
depressed	O
mood	I:C0344315
,	O
cognitive	O
impairment	I:C0338656
and	O
polypharmacy	O
were	O
the	O
geriatric	O
variables	O
significantly	O
and	O
independently	O
associated	O
with	O
disability	B:C0231170
.	O

Identifying	O
these	O
factors	O
prior	O
to	O
cancer	B:C0920425
treatment	I:C0920425
could	O
enable	O
the	O
implementation	O
of	O
corrective	O
actions	O
to	O
improve	O
patient	O
autonomy	O
before	O
treatment	O
and	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Identifying	O
these	O
factors	O
prior	O
to	O
cancer	O
treatment	I:C0920425
could	O
enable	O
the	O
implementation	O
of	O
corrective	O
actions	O
to	O
improve	O
patient	O
autonomy	O
before	O
treatment	B:C0920425
and	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Identifying	O
these	O
factors	O
prior	O
to	O
cancer	O
treatment	I:C0920425
could	O
enable	O
the	O
implementation	O
of	O
corrective	O
actions	O
to	O
improve	O
patient	O
autonomy	O
before	O
treatment	O
and	O
during	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
.	O

